Alegado, Kriezhel Jane M.

HRN: 28-51-42  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2026
CEFUROXIME 750MG (VIAL)
02/01/2026
02/07/2026
IVT
510mg
Q8H
T/C Nephritic Syndrome; UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines